| Product Code: ETC12942617 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for mRNA therapeutics in Mexico due to rising prevalence of chronic diseases |
4.2.2 Growing investments in research and development of mRNA-based therapies in the country |
4.2.3 Favorable regulatory environment supporting the development and manufacturing of mRNA therapeutics in Mexico |
4.3 Market Restraints |
4.3.1 High initial setup costs and infrastructure requirements for mRNA therapeutics contract development and manufacturing facilities |
4.3.2 Limited availability of skilled workforce specialized in mRNA technology in Mexico |
4.3.3 Stringent regulatory requirements and quality standards for mRNA therapeutics manufacturing in the country |
5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By Types |
6.1 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.1.7 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Therapeutics, 2021 - 2031F |
6.2.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031F |
6.2.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.3.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031F |
6.4.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Clinical Research Organizations, 2021 - 2031F |
6.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Lipid Nanoparticles, 2021 - 2031F |
6.5.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By In Vitro Transcription, 2021 - 2031F |
6.5.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Encapsulation Methods, 2021 - 2031F |
6.5.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.5.6 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By AI-Based Quality Control, 2021 - 2031F |
7 Mexico mRNA Therapeutics Contract Development Manufacturing Market Import-Export Trade Statistics |
7.1 Mexico mRNA Therapeutics Contract Development Manufacturing Market Export to Major Countries |
7.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Imports from Major Countries |
8 Mexico mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
8.1 Percentage of increase in mRNA therapeutics research funding in Mexico |
8.2 Number of partnerships and collaborations formed for mRNA therapeutics development in the country |
8.3 Rate of adoption of mRNA therapeutics manufacturing technologies in Mexico |
9 Mexico mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
9.1 Mexico mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Mexico mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Mexico mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mexico mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Mexico mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
10.1 Mexico mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Mexico mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here